Algert Global LLC T2 Biosystems, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.47 - $3.16 $40,817 - $87,743	-27,767 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$2.56 - $4.48 $98,775 - $172,856	-38,584 Reduced 58.15%	27,767 $73,000
Q4 2018 Feb 01, 2019	BUY	$2.98 - $6.86 $118,189 - $272,074	39,661 Added 148.6%	66,351 $200,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $143,058 - $208,982	26,690 New	26,690 $199,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $35.6M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.